Expand Document  |  Expand Chapter  |  Full TOC  |  Printable HTML version
WHO Pharmaceuticals Newsletter 2002, No. 02
(2002; 18 pages) View the PDF document
Table of Contents
View the documentEDITORIAL
Open this folder and view contentsREGULATORY MATTERS
Open this folder and view contentsSAFETY OF MEDICINES
Open this folder and view contentsDRUG OF CURRENT INTEREST
View the documentADVERSE DRUG REACTIONS (ADR) - ASSOCIATIONS
Open this folder and view contentsFEATURE
View the documentEVENTS & ANNOUNCEMENTS
 

WHO Pharmaceuticals Newsletter 2002, No. 02

prepared in collaboration with the
WHO Collaborating Centre for
International Drug Monitoring,
Uppsala, Sweden

The aim of this Newsletter is to disseminate information on the safety and efficacy of pharmaceutical products, based on information received from our network of “drug information officers” and other sources such as specialized bulletins and journals, as well as partners in WHO. The information is produced in the form of resumes in English full texts of which may be obtained on request from:

Quality Assurance and Safety:
Medicines, EDM-HTP
World Health Organization,
1211 Geneva 27, Switzerland
E-mail address: QSM@who.int
Fax: +41 22 791 4730

Further information on adverse reactions may be obtained from the
WHO Collaborating Centre for International Drug Monitoring,
Stora Target 3,
S-753 20 Uppsala, Sweden
Tel: 46-18-65.60.60
Fax: 46-18-65.60.80
E-mail: sten.olsson@who-umc.se
Internet: http://www.who-umc.org

 

to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: October 7, 2014